Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3626
CALL
Cogent Biosciences
COGT
$6.47B
| $567K | ﹤0.01% |
+79,000
| New | +$438K |
|
3627
Farmers & Merchants Bancorp
FMAO
$486M
| $567K | ﹤0.01% |
22,436
+9,656
| +76% | +$232K |
|
3628
Custom Truck One Source
CTOS
$2.33B
| $567K | ﹤0.01% |
114,760
+47,836
| +71% | +$206K |
|
3629
Safe Bulkers
SB
$781M
| $567K | ﹤0.01% |
157,036
+36,514
| +30% | +$131K |
|
3630
ClearPoint Neuro
CLPT
$470M
| $566K | ﹤0.01% |
47,388
-2,528
| -5% | -$31.8K |
|
|
PBPB
3631
DELISTED
Potbelly
PBPB
| $565K | ﹤0.01% |
46,098
+16,282
| +55% | +$160K |
|
|
LOVE
3632
LoveSac
LOVE
$258M
| $564K | ﹤0.01% |
30,963
+15,090
| +95% | +$286K |
|
3633
E.W. Scripps
SSP
$310M
| $563K | ﹤0.01% |
191,461
-205,688
| -52% | -$497K |
|
3634
Enlight Renewable Energy
ENLT
$12B
| $561K | ﹤0.01% |
24,670
+18
| +0.1% | +$326 |
|
3635
Nano X Imaging
NNOX
$73.2M
| $560K | ﹤0.01% |
108,321
+24,251
| +29% | +$124K |
|
3636
ODDITY Tech
ODD
$615M
| $560K | ﹤0.01% |
7,416
+409
| +6% | +$24.9K |
|
3637
Dakota Gold
DC
$827M
| $557K | ﹤0.01% |
150,917
+77,065
| +104% | +$241K |
|
|
TTAM
3638
Titan America SA
TTAM
$2.9B
| $552K | ﹤0.01% |
+44,252
| New | +$586K |
|
3639
Lightbridge
LTBR
$327M
| $552K | ﹤0.01% |
41,296
+41,200
| +42,917% | +$455K |
|
|
GRDN
3640
Guardian Pharmacy Services
GRDN
$2.44B
| $552K | ﹤0.01% |
25,898
+16,964
| +190% | +$383K |
|
3641
Sony
SONY
$138B
| $552K | ﹤0.01% |
21,200
+7,012
| +49% | +$175K |
|
3642
Latham Group
SWIM
$889M
| $552K | ﹤0.01% |
86,490
+37,309
| +76% | +$217K |
|
|
CEPT
3643
DELISTED
Cantor Equity Partners II
CEPT
| $552K | ﹤0.01% |
+50,000
| New | +$565K |
|
3644
Oportun Financial
OPRT
$351M
| $550K | ﹤0.01% |
76,794
+53,352
| +228% | +$320K |
|
3645
CALL
Nu Holdings
NU
$67.3B
| $549K | ﹤0.01% |
+40,000
| New | +$479K |
|
3646
Franklin Covey
FC
$227M
| $549K | ﹤0.01% |
24,041
+7,635
| +47% | +$169K |
|
3647
First Trust NASDAQ Cybersecurity ETF
CIBR
$16B
| $548K | ﹤0.01% |
7,256
-1,040
| -13% | -$71.3K |
|
3648
Petco
WOOF
$817M
| $548K | ﹤0.01% |
193,668
+670
| +0.3% | +$2.08K |
|
3649
PUT
Lumen
LUMN
$6.6B
| $548K | ﹤0.01% |
125,000
| – | – |
|
|
HDSN
3650
Hudson Technologies
HDSN
$239M
| $547K | ﹤0.01% |
67,394
+22,258
| +49% | +$153K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.